Product
SGT-003
1 clinical trial
1 indication
Indication
Duchenne muscular dystrophyClinical trial
A Phase 1/2, Multicenter, Open-Label Study to Investigate the Safety, Tolerability, and Efficacy of a Single Intravenous Dose of SGT-003 in Ambulant Males With Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)Status: Recruiting, Estimated PCD: 2026-01-15